OpenVSafe by OpenVAERS
Search V-safe

NY3-12675-33820

2 vaccinations 2 coded responses 15 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
435 / OH
Registered
2020-12-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-31
    Registered in v-safe
  3. 2020-12-31
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-13
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  6. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  7. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-07-15
    Survey response — 6 months, dose 2
    MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Gestational diabetes (reported during v-safe call with CDC)
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  18. 2021-07-15
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-07-20
  20. 2022-01-16
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-14Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-18

Systemic reaction (other): Axillary lymphadenopathy

Release 9 — 6 months, dose 2

2021-07-15

Symptoms: Gestational diabetes (reported during v-safe call with CDC)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGestational diabetes ✓ · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…